CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300765 CSPC Innovation Pharmaceutical
- 41.91
- +2.31+5.83%
Market Closed Apr 30 15:00 CST
58.87BMarket Cap-1132.70P/E (TTM)
41.91High37.90Low227.27KlotVolume39.50Open39.60Pre Close906.03MTurnover1.82%Turnover Ratio1102.89P/E (Static)1.40BShares48.4552wk High15.89P/B52.26BFloat Cap21.0752wk Low47.52Limit Up1.25BShs Float48.45Historical High31.68Limit Down10.13%Amplitude4.52Historical Low0.27Dividend TTM39.87Avg Price97.05KlotAsk0.64%Div YieldTTM100Lot Size108.95KlotBid
CSPC Innovation Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.94%471.97M | -21.98%1.98B | -23.66%1.48B | -27.71%971.86M | -27.08%524.07M | -3.34%2.54B | 2.33%1.94B | 8.26%1.34B | 32.84%718.72M | 42.00%2.63B |
| Operating revenue | -9.94%471.97M | -21.98%1.98B | -23.66%1.48B | -27.71%971.86M | -27.08%524.07M | -3.34%2.54B | 2.33%1.94B | 8.26%1.34B | 32.84%718.72M | 42.00%2.63B |
| Other operating revenue | ---- | -1.90%52.64M | ---- | 16.08%28.68M | ---- | -2.87%53.66M | ---- | -22.13%24.71M | ---- | -8.14%55.25M |
| Total operating cost | 30.94%601.33M | -3.65%2.22B | -12.23%1.46B | -21.51%904.05M | -24.61%459.22M | 28.92%2.3B | 29.84%1.66B | 36.61%1.15B | 57.71%609.16M | 28.31%1.79B |
| Operating cost | 1.52%283.55M | -16.04%1.15B | -16.79%843.1M | -22.71%546.32M | -23.96%279.3M | -8.22%1.37B | -5.77%1.01B | 0.72%706.85M | 23.21%367.33M | 43.25%1.49B |
| Operating tax surcharges | -18.13%7.25M | -12.44%32.59M | -13.62%24.49M | -8.71%16.88M | -5.03%8.85M | 81.32%37.22M | 97.65%28.35M | 106.28%18.49M | 163.71%9.32M | 29.92%20.53M |
| Operating expense | 23.68%65.6M | -26.73%154.24M | -38.97%107.92M | -35.68%73.26M | -21.44%53.04M | -13.82%210.5M | -4.68%176.83M | -6.69%113.91M | -1.97%67.51M | -8.11%244.25M |
| Administration expense | -19.92%18.98M | -12.75%82.18M | -5.69%57.26M | 0.16%43.08M | 30.91%23.71M | 35.49%94.19M | 30.41%60.71M | 57.31%43.01M | 46.73%18.11M | 16.92%69.52M |
| Financial expense | 10.00%-14.54M | 46.81%-42.86M | 43.35%-29.36M | 9.32%-27.35M | -356.32%-16.15M | 7.15%-80.57M | 23.59%-51.83M | 2.33%-30.16M | 251.75%6.3M | -401.59%-86.78M |
| -Interest expense (Financial expense) | 22,664.50%4.03M | -63.84%6.37M | -81.79%2.88M | -78.14%2.86M | -91.92%17.71K | 7,939.72%17.63M | 2,118.56%15.79M | 2,036.96%13.09M | 2,297.12%219.23K | -92.26%219.23K |
| -Interest Income (Financial expense) | 76.84%-3.29M | 42.45%-42.21M | 28.80%-33.48M | 15.27%-24.74M | 56.61%-14.21M | -123.95%-73.34M | -135.08%-47.02M | -111.21%-29.19M | -369.57%-32.75M | -18.40%-32.75M |
| Research and development | 117.68%240.48M | 25.44%842.2M | 4.67%456.96M | -15.97%251.86M | -21.42%110.48M | 1,350.10%671.4M | 1,479.81%436.56M | 2,069.64%299.71M | 1,767.95%140.59M | 74.71%46.3M |
| Credit Impairment Loss | 44.24%-2.91M | -59.09%2.3M | -238.69%-3.49M | -462.24%-1.78M | -1,424.00%-5.22M | 171.91%5.62M | 132.78%2.51M | 108.02%491.7K | 87.47%-342.21K | -30.32%-7.82M |
| Asset Impairment Loss | ---- | 80.92%-2.28M | ---625K | ---625K | ---- | ---11.94M | ---- | ---- | ---- | ---- |
| Other net revenue | 132.05%2.78M | -24.11%18.66M | -92.18%949.31K | -110.62%-818.34K | -620.97%-8.69M | 69.75%24.58M | 653.61%12.15M | 594.61%7.7M | 265.94%1.67M | -50.38%14.48M |
| Fair value change income | ---- | --89.69K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 93.03%-321.48K | -107.76%-976.74K | -257.12%-2.85M | -500.40%-3.79M | -554.56%-4.61M | -25.21%12.58M | -64.97%1.81M | -52.01%947.48K | -151.09%-704.63K | -5.05%16.82M |
| -Including: Investment income associates | 45.76%-2.5M | -120.83%-2.62M | -257.12%-2.85M | -500.40%-3.79M | ---4.61M | 22.10%12.58M | 117.17%1.81M | 737.19%947.48K | ---- | 40.92%10.3M |
| Asset deal income | --1.68M | --545.29K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --117.54K |
| Other revenue | 280.63%4.33M | 3.59%18.97M | 1.14%7.91M | -14.09%5.38M | -58.09%1.14M | 241.59%18.32M | 176.78%7.82M | 243.96%6.26M | 681.64%2.71M | -70.57%5.36M |
| Operating profit | -325.40%-126.57M | -183.48%-218.34M | -93.17%19.51M | -66.54%67M | -49.51%56.16M | -69.43%261.55M | -53.44%285.57M | -49.57%200.21M | -27.67%111.22M | 75.55%855.59M |
| Add:Non operating Income | -13.64%568.1K | -68.38%961.9K | -77.40%1.48M | -73.34%934.58K | -12.79%657.86K | 22.01%3.04M | -2.51%6.54M | 62.25%3.51M | 21.53%754.32K | 183.72%2.49M |
| Less:Non operating expense | 7,125.52%2.12M | 59.87%3.92M | -16.72%1.86M | 239.52%915.13K | --29.32K | -63.44%2.45M | -63.26%2.24M | -95.14%269.53K | ---- | -34.56%6.71M |
| Total profit | -325.63%-128.12M | -184.42%-221.3M | -93.40%19.12M | -67.06%67.02M | -49.29%56.78M | -69.21%262.14M | -52.79%289.88M | -48.32%203.45M | -25.70%111.98M | 78.11%851.37M |
| Less:Income tax cost | -46.92%14.24M | -39.98%81.91M | -35.62%65.61M | -43.85%38.62M | -19.53%26.82M | 9.39%136.47M | 6.01%101.9M | 11.64%68.77M | 22.46%33.33M | 46.28%124.76M |
| Net profit | -575.15%-142.36M | -341.28%-303.21M | -124.73%-46.48M | -78.91%28.4M | -61.90%29.96M | -82.71%125.67M | -63.70%187.97M | -59.44%134.68M | -36.32%78.65M | 85.03%726.61M |
| Net profit from continuing operation | -575.15%-142.36M | -341.28%-303.21M | -124.73%-46.48M | -78.91%28.4M | -61.90%29.96M | -82.71%125.67M | --187.97M | -59.44%134.68M | -36.32%78.65M | 85.03%726.61M |
| Less:Minority Profit | -135.15%-115.46M | -15.60%-356.94M | 4.11%-185.81M | 16.58%-108.63M | 3.07%-49.1M | -92,605.67%-308.77M | -60,544.35%-193.78M | -64,950.89%-130.22M | -286,426.55%-50.66M | 163.23%333.78K |
| Net profit of parent company owners | -134.03%-26.9M | -87.63%53.73M | -63.50%139.33M | -48.27%137.03M | -38.86%79.06M | -40.18%434.44M | -26.23%381.76M | -20.18%264.9M | 4.68%129.3M | 84.70%726.28M |
| Earning per share | ||||||||||
| Basic earning per share | -128.40%-0.0192 | -87.65%0.0384 | -63.66%0.0995 | -47.37%0.1 | -40.44%0.0676 | -52.29%0.311 | -48.01%0.2738 | -43.74%0.19 | -43.11%0.1135 | 2.61%0.6519 |
| Diluted earning per share | -128.40%-0.0192 | -87.65%0.0384 | -63.66%0.0995 | -47.37%0.1 | -40.44%0.0676 | -52.29%0.311 | -48.01%0.2738 | -43.74%0.19 | -43.11%0.1135 | 2.61%0.6519 |
| Other composite income | 112.78%47.59K | -59.56%511.55K | -151.38%-502.39K | -122.58%-382.21K | -212.69%-372.43K | -34.15%1.27M | 186.59%977.86K | 277.73%1.69M | -134.91%-119.11K | 273.95%1.92M |
| Other composite income of parent company owners | 112.78%47.59K | -59.56%511.55K | -151.38%-502.39K | -122.58%-382.21K | -212.69%-372.43K | -34.15%1.27M | 186.59%977.86K | 277.73%1.69M | -134.91%-119.11K | 273.95%1.92M |
| Total composite income | -580.97%-142.31M | -338.47%-302.7M | -124.87%-46.98M | -79.46%28.02M | -62.32%29.59M | -82.58%126.93M | -63.54%188.95M | -58.99%136.37M | -36.59%78.53M | 86.04%728.53M |
| Total composite income of parent company owners | -134.13%-26.85M | -87.55%54.24M | -63.73%138.83M | -48.74%136.65M | -39.09%78.69M | -40.17%435.7M | -26.09%382.73M | -19.77%266.59M | 4.30%129.18M | 85.71%728.2M |
| Total composite income of minority owners | -135.15%-115.46M | -15.60%-356.94M | 4.11%-185.81M | 16.58%-108.63M | 3.07%-49.1M | -92,605.67%-308.77M | -60,544.35%-193.78M | -64,950.89%-130.22M | -286,426.55%-50.66M | 163.23%333.78K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.